Two new rotenoids, boerharotenoids A (1) and B (2), and four known compounds, boeravinone (3), 5,7,3′-trihydroxycoumaronochromone (4), boeravinone F (5), and eupalitin-3-O-β-D-galactopyranoside (6), have been isolated from Boerhavia repens and their structures established by spectroscopic (1D and 2D NMR) and mass spectrometric comparison with literature values.
PandeyR, MauryaR, SinghG, SathiamoorthyB, NaikS. (2005) Immunosuppressive properties of flavonoids isolated from Boerhaavia diffusa Linn. International Immunopharmacology, 5, 541–553;
2.
BurkillHM. (1997) The useful plants of West Tropical Africa. 2nd Ed., Families M–R. Royal Botanic Gardens, Kew, Richmond, United Kingdom. Vol. 4, p. 969.
3.
CoddLE. (1966) Notes on Boerhavia in Southern Africa. Bothalia, 9, 113–121;
4.
Data provided by the Desert Dwellers and Researchers at Cholistan Institute for Desert Studies, the Islamia University of Bahawalpur.
5.
MauryaR, SathiamoorthyB, DeepakM. (2007) Flavonoids and phenol glycosides from Boerhavia diffusa. Natural Product Research, 21, 126–134;
6.
MessanaI, FerrariF, SantanaAEG. (1986) Two 12α-hydroxyrotenoids from Boerhaavia coccznea. Phytochemistry, 25, 2688–2689;
YangS-W, UbillasR, McAlpineJ, StaffordA, EckerDM, TalbotMK, RogersB. (2001) Three new phenolic compounds from a manipulated plant cell culture, Mirabilis jalapa. Journal of Natural Products, 64, 313–317.
9.
FerrariF, MessanaI. (1991) Two new isoflavonoids from Boerhaavia coccinea. Journal of Natural Products, 54, 597–598.
10.
Yi-FenW, Ji-JunC, YanY, Yong-TangZ, Shao-ZongT, Shi-DeL. (2002) New rotenoids from roots of Mirabilis jalapa. Helvetica Chimica Acta, 85, 2342–2347;
11.
LamiN, KadotaS, KikuchiT. (1991) Constituents of the roots of Boerhaavia diffusa L IV. Isolation and structure determination of boeravinones D, E and F. Chemical and Pharmaceutical Bulletin, 39, 1863–1865.
12.
BorrelliF, MilicN, AscioneV, CapassoR, IzzoAA, CapassoF, PetrucciF, ValenteR, FattorussoE, Taglialatela-ScafatiO. (2005) Isolation of new rotenoids from Boerhaavia diffusa and evaluation of their effect on intestinal motility. Planta Medica, 71, 928–932;
13.
NicolleE, BoccardJ, GuiletD, Dijoux-FrancaM-G, ZelefacF, MacalouS, GrosselinJ, SchmidtJ, CarruptP-A, PietroAD, BoumendjelA. (2009) Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation energy approach. European Journal of Pharmaceutical Sciences, 38, 39–46.
